PON1 and neurodegenerative disease: Reduced PON1 and ARE activities have been associated with neurodegenerative diseases, such as Alzheimer’s and Parkinson’s [22], as well as metabolic disorders like type 2 diabetes, where they exacerbate oxidative stress and inflammation [23].